Global standards are increasingly focusing on risk assessment methods to prevent cross-contamination between drugs in shared production sites. These guidelines aim to establish health-based exposure limits for Active Pharmaceutical Ingredients (APIs) to ensure the safety of both human and veterinary medicines.